W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 24.8 HKD -5.16% Market Closed
Market Cap: 29.7B HKD
Have any thoughts about
WuXi XDC Cayman Inc?
Write Note

WuXi XDC Cayman Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

WuXi XDC Cayman Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
W
WuXi XDC Cayman Inc
HKEX:2268
Cash & Cash Equivalents
ÂĄ4B
CAGR 3-Years
422%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash & Cash Equivalents
ÂĄ14.7B
CAGR 3-Years
14%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash & Cash Equivalents
ÂĄ2.3B
CAGR 3-Years
-27%
CAGR 5-Years
46%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash & Cash Equivalents
ÂĄ9.2B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash & Cash Equivalents
ÂĄ3.2B
CAGR 3-Years
-30%
CAGR 5-Years
7%
CAGR 10-Years
23%
Genscript Biotech Corp
HKEX:1548
Cash & Cash Equivalents
$1.4B
CAGR 3-Years
15%
CAGR 5-Years
39%
CAGR 10-Years
N/A

See Also

What is WuXi XDC Cayman Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
4B CNY

Based on the financial report for Dec 31, 2023, WuXi XDC Cayman Inc's Cash & Cash Equivalents amounts to 4B CNY.

What is WuXi XDC Cayman Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
422%

Over the last year, the Cash & Cash Equivalents growth was 1 108%. The average annual Cash & Cash Equivalents growth rates for WuXi XDC Cayman Inc have been 422% over the past three years .

Back to Top